<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T09:46:01Z</responseDate>
  <request identifier="oai:figshare.com:article/34013767" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34013767</identifier>
        <datestamp>2026-09-28T12:35:26Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Neuroprotective Effects of &lt;i&gt;Nanocurcumin&lt;/i&gt; in Spinal Cord Injury: Modulation of Inflammatory and Inflammasome-Associated Signaling in an Integrated &lt;i&gt;In Vivo&lt;/i&gt;, &lt;i&gt;In Silico&lt;/i&gt;, and Machine-Learning Study</dc:title>
          <dc:creator>Seyyedeh Fahimeh Talebi (25122415)</dc:creator>
          <dc:creator>Jalal Mardaneh (13744039)</dc:creator>
          <dc:creator>Mohammad Matin Alishani (19434487)</dc:creator>
          <dc:creator>Abeer Ali Kadhim (25122418)</dc:creator>
          <dc:creator>Pasha Mosaed (25122421)</dc:creator>
          <dc:creator>Ako Mohammadi (25122424)</dc:creator>
          <dc:creator>Sajad Najafi (8523714)</dc:creator>
          <dc:creator>Jamal Majidpoor (18301825)</dc:creator>
          <dc:creator>Hamed Shoorei (10272620)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>Spinal Cord Injury</dc:subject>
          <dc:subject>Nanocurcumin</dc:subject>
          <dc:subject>Inflammasome</dc:subject>
          <dc:subject>Inflammation</dc:subject>
          <dc:subject>In Silico</dc:subject>
          <dc:subject>Machine-Learning</dc:subject>
          <dc:description>&lt;p&gt;Spinal cord injury (SCI) triggers secondary neuroinflammatory and inflammasome-associated responses that contribute to tissue damage and functional impairment. This study evaluated &lt;i&gt;nanocurcumin&lt;/i&gt; in experimental SCI using integrated experimental, computational, and exploratory machine-learning approaches. Adult male Wistar rats were allocated to Sham, SCI, or SCI + &lt;i&gt;nanocurcumin&lt;/i&gt; groups. SCI was induced by T6 contusion, and &lt;i&gt;nanocurcumin&lt;/i&gt; (50 mg/kg, intraperitoneally) was administered every 12 hours for 72 hours. Functional, histological, molecular, and inflammatory outcomes were assessed using BBB scoring, Luxol Fast Blue staining, immunofluorescence, RT-qPCR, and ELISA. SCI impaired locomotor function and myelin integrity and increased inflammasome-associated and inflammatory markers. &lt;i&gt;Nanocurcumin&lt;/i&gt; significantly improved BBB scores, increased the LFB-positive myelinated area, and attenuated these molecular alterations. Tissue IL-1β, IL-18, HMGB1, and TLR4 levels were also reduced following &lt;i&gt;nanocurcumin&lt;/i&gt; treatment compared with untreated SCI. Correlation and hierarchical clustering analyses demonstrated coordinated molecular–functional associations and separation of SCI from control and treated profiles. Exploratory Random Forest/SHAP analyses highlighted NF-κB, Caspase-1, NOX2, and NLRP3 as influential variables for group discrimination. Docking predicted favorable curcumin–target interactions, while MD simulations supported distinct conformational behavior of selected complexes. Overall, &lt;i&gt;nanocurcumin&lt;/i&gt; was associated with attenuated inflammatory and inflammasome-associated responses and improved early functional and histological outcomes following SCI.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T12:35:26Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.34013767.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Neuroprotective_Effects_of_i_Nanocurcumin_i_in_Spinal_Cord_Injury_Modulation_of_Inflammatory_and_Inflammasome-Associated_Signaling_in_an_Integrated_i_In_Vivo_i_i_In_Silico_i_and_Machine-Learning_Study/34013767</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
